Literature DB >> 17991740

Cathepsins B, K, and L are regulated by a defined collagen type II peptide via activation of classical protein kinase C and p38 MAP kinase in articular chondrocytes.

Anke Ruettger1, Susann Schueler, Juergen A Mollenhauer, Bernd Wiederanders.   

Abstract

Degradation of the extracellular matrix (ECM) is a prominent feature in osteoarthritis (OA), which is mainly because of the imbalance between anabolic and catabolic processes in chondrocytes resulting in cartilage and bone destruction. Various proteases act in concert to degrade matrix components, e.g. type II collagen, MMPs, ADAMTS, and cathepsins. Protease-generated collagen fragments may foster the destructive process. However, the signaling pathways associated with the action of collagen fragments on chondrocytes have not been clearly defined. The present data demonstrate that the N-terminal telopeptide of collagen type II enhances expression of cathepsins B, K, and L in articular chondrocytes at mRNA, protein, and activity levels, mediated at least in part through extracellular calcium. We also demonstrate that the induction is associated with the activation of protein kinase C and p38 MAP kinase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991740     DOI: 10.1074/jbc.M704915200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation.

Authors:  Jie Zhang; Jiusong Sun; Jes S Lindholt; Galina K Sukhova; Mark Sinnamon; Richard L Stevens; Roberto Adachi; Peter Libby; Robert W Thompson; Guo-Ping Shi
Journal:  Circ Res       Date:  2011-04-14       Impact factor: 17.367

Review 2.  Mitogen-activated protein kinases as therapeutic targets in osteoarthritis.

Authors:  Richard F Loeser; Elizabeth A Erickson; David L Long
Journal:  Curr Opin Rheumatol       Date:  2008-09       Impact factor: 5.006

3.  Mechanical impact induces cartilage degradation via mitogen activated protein kinases.

Authors:  L Ding; E Heying; N Nicholson; N J Stroud; G A Homandberg; J A Buckwalter; D Guo; J A Martin
Journal:  Osteoarthritis Cartilage       Date:  2010-09-09       Impact factor: 6.576

4.  Trichostatin A inhibits expression of cathepsins in experimental osteoarthritis.

Authors:  Wei-Ping Chen; Jia-Peng Bao; Jin-Li Tang; Peng-Fei Hu; Li-Dong Wu
Journal:  Rheumatol Int       Date:  2011-10       Impact factor: 2.631

5.  Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.

Authors:  Claudia D Andl; Kelsey M McCowan; Gillian L Allison; Anil K Rustgi
Journal:  Neoplasia       Date:  2010-06       Impact factor: 5.715

Review 6.  Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned.

Authors:  Matthew T Drake; Bart L Clarke; Merry Jo Oursler; Sundeep Khosla
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

7.  p38gamma mitogen-activated protein kinase suppresses chondrocyte production of MMP-13 in response to catabolic stimulation.

Authors:  D L Long; R F Loeser
Journal:  Osteoarthritis Cartilage       Date:  2010-07-13       Impact factor: 6.576

8.  Comparison of different methods for preparation and characterization of total RNA from cartilage samples to uncover osteoarthritis in vivo.

Authors:  Anke Ruettger; Steffi Neumann; Bernd Wiederanders; René Huber
Journal:  BMC Res Notes       Date:  2010-01-18

Review 9.  Analysing the role of endogenous matrix molecules in the development of osteoarthritis.

Authors:  Nidhi Sofat
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

10.  Tumor necrosis factor alpha stimulates cathepsin K and V activity via juxtacrine monocyte-endothelial cell signaling and JNK activation.

Authors:  Philip M Keegan; Catera L Wilder; Manu O Platt
Journal:  Mol Cell Biochem       Date:  2012-05-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.